Stock Earnings

Question 1

What are Ascendis Pharma A/S's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ascendis Pharma A/S has a total asset of $1,179, Net loss of $-378

Question 2

What are the key financial ratios for ASND?

Accepted Answer

Ascendis Pharma A/S's Current ratio is 0.91, has a Net margin is -104.13, sales per share of $6.27.

Question 3

How is Ascendis Pharma A/S's revenue broken down by segment or geography?

Accepted Answer

Ascendis Pharma A/S largest revenue segment is Pharmaceutical Products, at a revenue of 393,347,104 in the most earnings release.For geography, North America is the primary market for Ascendis Pharma A/S, at a revenue of 252,271,915.

Question 4

Is Ascendis Pharma A/S profitable?

Accepted Answer

no, according to the latest financial statements, Ascendis Pharma A/S has a net loss of $-378

Question 5

Does Ascendis Pharma A/S have any liabilities?

Accepted Answer

yes, Ascendis Pharma A/S has liability of 1,285

Question 6

How many outstanding shares for Ascendis Pharma A/S?

Accepted Answer

Ascendis Pharma A/S has a total outstanding shares of 60.68

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	646	363	266	51	7	6
Revenue Growth (YoY)	98%	36%	422%	629%	17%	-54%
Cost of Revenue	85	44	44	12	3	--
Gross Profit	561	319	222	39	4	--
Selling, General & Admin	391	284	258	215	155	72
Research & Development	292	299	395	368	285	248
Operating Expenses	706	598	670	600	456	337
Other Non Operating Income (Expenses)	--	-27	0	-4	--	--
Pretax Income	-223	-373	-474	-577	-383	-419
Income Tax Expense	9	4	7	5	0	0
Net Income	-232	-378	-481	-583	-383	-418
Net Income Growth	-46%	-21%	-18%	52%	-8%	92%
Shares Outstanding (Diluted)	60.75	57.89	56.28	56.07	54.77	50.62
Shares Change (YoY)	6%	3%	0%	2%	8%	9%
EPS (Diluted)	-3.83	-6.53	-8.55	-10.4	-7	-8.28
EPS Growth	-48%	-24%	-18%	49%	-15%	77%
Free Cash Flow	-112	-307	-469	-510	-441	-293
Free Cash Flow Per Share	-1.84	-5.3	-8.33	-9.09	-8.05	-5.78
Gross Margin	86.84%	87.87%	83.45%	76.47%	57.14%	--
Operating Margin	-22.44%	-76.58%	-168.04%	-1,100%	-6,442.85%	-5,500%
Profit Margin	-35.91%	-104.13%	-180.82%	-1,143.13%	-5,471.42%	-6,966.66%
Free Cash Flow Margin	-17.33%	-84.57%	-176.31%	-1,000%	-6,300%	-4,883.33%
EBITDA	-128	-264	-431	-545	-437	-314
EBITDA Margin	-19.81%	-72.72%	-162.03%	-1,068.62%	-6,242.85%	-5,233.33%
D&A For EBITDA	17	14	16	16	14	16
EBIT	-145	-278	-447	-561	-451	-330
EBIT Margin	-22.44%	-76.58%	-168.04%	-1,100%	-6,442.85%	-5,500%
Effective Tax Rate	-4.03%	-1.07%	-1.47%	-0.86%	0%	0%

Ascendis Pharma A/S (ASND) Price

ASND Stock Price Chart

ASND Income

Follow-Up Questions